254 related articles for article (PubMed ID: 29713822)
1. Improving Viscosity and Stability of a Highly Concentrated Monoclonal Antibody Solution with Concentrated Proline.
Hung JJ; Dear BJ; Dinin AK; Borwankar AU; Mehta SK; Truskett TT; Johnston KP
Pharm Res; 2018 Apr; 35(7):133. PubMed ID: 29713822
[TBL] [Abstract][Full Text] [Related]
2. Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody.
Dear BJ; Hung JJ; Truskett TM; Johnston KP
Pharm Res; 2017 Jan; 34(1):193-207. PubMed ID: 27837522
[TBL] [Abstract][Full Text] [Related]
3. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
[TBL] [Abstract][Full Text] [Related]
4. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
Liu J; Nguyen MD; Andya JD; Shire SJ
J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
[TBL] [Abstract][Full Text] [Related]
5. Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions.
Binabaji E; Ma J; Zydney AL
Pharm Res; 2015 Sep; 32(9):3102-9. PubMed ID: 25832501
[TBL] [Abstract][Full Text] [Related]
6. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
[TBL] [Abstract][Full Text] [Related]
7. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies.
Wang S; Zhang N; Hu T; Dai W; Feng X; Zhang X; Qian F
Mol Pharm; 2015 Dec; 12(12):4478-87. PubMed ID: 26528726
[TBL] [Abstract][Full Text] [Related]
8. Self-diffusion of a highly concentrated monoclonal antibody by fluorescence correlation spectroscopy: insight into protein-protein interactions and self-association.
Hung JJ; Zeno WF; Chowdhury AA; Dear BJ; Ramachandran K; Nieto MP; Shay TY; Karouta CA; Hayden CC; Cheung JK; Truskett TM; Stachowiak JC; Johnston KP
Soft Matter; 2019 Aug; 15(33):6660-6676. PubMed ID: 31389467
[TBL] [Abstract][Full Text] [Related]
9. Characterizing monoclonal antibody formulations in arginine glutamate solutions using
Kheddo P; Cliff MJ; Uddin S; van der Walle CF; Golovanov AP
MAbs; 2016 Oct; 8(7):1245-1258. PubMed ID: 27589351
[TBL] [Abstract][Full Text] [Related]
10. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
[TBL] [Abstract][Full Text] [Related]
11. Both Reversible Self-Association and Structural Changes Underpin Molecular Viscoelasticity of mAb Solutions.
Sarangapani PS; Weaver J; Parupudi A; Besong TMD; Adams GG; Harding SE; Manikwar P; Castellanos MM; Bishop SM; Pathak JA
J Pharm Sci; 2016 Dec; 105(12):3496-3506. PubMed ID: 27793346
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.
Yadav S; Shire SJ; Kalonia DS
J Pharm Sci; 2010 Dec; 99(12):4812-29. PubMed ID: 20821382
[TBL] [Abstract][Full Text] [Related]
13. The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions.
Prašnikar M; Proj M; Bjelošević Žiberna M; Lebar B; Knez B; Kržišnik N; Roškar R; Gobec S; Grabnar I; Žula A; Ahlin Grabnar P
Int J Pharm; 2024 Apr; 655():124055. PubMed ID: 38554741
[TBL] [Abstract][Full Text] [Related]
14. Protein-Protein Interactions of Highly Concentrated Monoclonal Antibody Solutions via Static Light Scattering and Influence on the Viscosity.
Hung JJ; Dear BJ; Karouta CA; Chowdhury AA; Godfrin PD; Bollinger JA; Nieto MP; Wilks LR; Shay TY; Ramachandran K; Sharma A; Cheung JK; Truskett TM; Johnston KP
J Phys Chem B; 2019 Jan; 123(4):739-755. PubMed ID: 30614707
[TBL] [Abstract][Full Text] [Related]
15. Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.
Baek Y; Singh N; Arunkumar A; Zydney AL
Pharm Res; 2017 Mar; 34(3):629-639. PubMed ID: 28035628
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Stability and Reducing Viscosity of a Monoclonal Antibody With Cosolutes by Weakening Protein-Protein Interactions.
Dear BJ; Hung JJ; Laber JR; Wilks LR; Sharma A; Truskett TM; Johnston KP
J Pharm Sci; 2019 Aug; 108(8):2517-2526. PubMed ID: 30885659
[TBL] [Abstract][Full Text] [Related]
17. Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.
Salinas BA; Sathish HA; Bishop SM; Harn N; Carpenter JF; Randolph TW
J Pharm Sci; 2010 Jan; 99(1):82-93. PubMed ID: 19475558
[TBL] [Abstract][Full Text] [Related]
18. Specific interactions in high concentration antibody solutions resulting in high viscosity.
Yadav S; Liu J; Shire SJ; Kalonia DS
J Pharm Sci; 2010 Mar; 99(3):1152-68. PubMed ID: 19705420
[TBL] [Abstract][Full Text] [Related]
19. Prediction of colloidal stability of high concentration protein formulations.
Garidel P; Blume A; Wagner M
Pharm Dev Technol; 2015 May; 20(3):367-74. PubMed ID: 24392929
[TBL] [Abstract][Full Text] [Related]
20. Characterization of highly concentrated antibody solution - A toolbox for the description of protein long-term solution stability.
Schermeyer MT; Wöll AK; Kokke B; Eppink M; Hubbuch J
MAbs; 2017 Oct; 9(7):1169-1185. PubMed ID: 28617076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
